carvedilol has been researched along with Cholestasis, Intrahepatic in 1 studies
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rivaroxaban, a highly selective direct factor Xa inhibitor, is a new oral anticoagulant approved by the US Food and Drug Administration in November 2011 for stroke prophylaxis in patients with nonvalvular atrial fibrillation." | 7.83 | Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban. ( Akçay, M; Aslan, AN; Baştuğ, S; Bozkurt, E; Durmaz, T; Sari, C; Sari, SÖ, 2016) |
| "Rivaroxaban, a highly selective direct factor Xa inhibitor, is a new oral anticoagulant approved by the US Food and Drug Administration in November 2011 for stroke prophylaxis in patients with nonvalvular atrial fibrillation." | 3.83 | Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban. ( Akçay, M; Aslan, AN; Baştuğ, S; Bozkurt, E; Durmaz, T; Sari, C; Sari, SÖ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, AN | 1 |
| Sari, C | 1 |
| Baştuğ, S | 1 |
| Sari, SÖ | 1 |
| Akçay, M | 1 |
| Durmaz, T | 1 |
| Bozkurt, E | 1 |
1 other study available for carvedilol and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban.
Topics: Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Cholesta | 2016 |